Diabetic Nephropathy Plasma

Diabetic Nephropathy Plasma | High-Quality Human Plasma from Diabetic Nephropathy Donors

Diabetic Nephropathy Plasma is collected from donors clinically diagnosed with Diabetic Nephropathy and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in diabetic nephropathy pathophysiology.

Product Features

  • Research Use Only (RUO)
  • Plasma collected from clinically confirmed Diabetic Nephropathy donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

De-identified Donor Data

  • Verified Diabetic Nephropathy diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional diabetic nephropathy-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Diabetic Nephropathy plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Frequently Asked Questions

×

Ask a Question

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information